Home Cart 0 Sign in  

[ CAS No. 1074-68-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1074-68-6
Chemical Structure| 1074-68-6
Structure of 1074-68-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1074-68-6 ]

Related Doc. of [ 1074-68-6 ]

Alternatived Products of [ 1074-68-6 ]

Product Details of [ 1074-68-6 ]

CAS No. :1074-68-6 MDL No. :MFCD02683211
Formula : C6H6N2OS Boiling Point : -
Linear Structure Formula :- InChI Key :QGJXHPACBLAFFJ-UHFFFAOYSA-N
M.W : 154.19 Pubchem ID :15407008
Synonyms :

Calculated chemistry of [ 1074-68-6 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 39.14
TPSA : 68.15 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.64 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.02
Log Po/w (XLOGP3) : 0.84
Log Po/w (WLOGP) : 1.01
Log Po/w (MLOGP) : -0.43
Log Po/w (SILICOS-IT) : 1.57
Consensus Log Po/w : 0.8

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.64
Solubility : 3.56 mg/ml ; 0.0231 mol/l
Class : Very soluble
Log S (Ali) : -1.85
Solubility : 2.16 mg/ml ; 0.014 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.08
Solubility : 1.27 mg/ml ; 0.00826 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.4

Safety of [ 1074-68-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1074-68-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1074-68-6 ]
  • Downstream synthetic route of [ 1074-68-6 ]

[ 1074-68-6 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 1074-68-6 ]
  • [ 1126-44-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 11, p. 2724 - 2727
  • 2
  • [ 180869-36-7 ]
  • [ 1074-68-6 ]
YieldReaction ConditionsOperation in experiment
34%
Stage #1: With hydrogenchloride In water at 60℃; for 3 h;
Stage #2: With sodium hydrogencarbonate In water
Example 4 2-(methylthio)pyrimidine-4-carbaldehyde (4): 4-(dimethoxymethyl)-2-(methylthio)pyrimidine (3) (53.7 g, 268 mmol) was added carefully to 1.2 N aqueous HCl (300 mL, 268 mmol, 1.0 equiv.) and stirred at 60° C. for 3 hours. The reaction mixture was then cooled to room temperature and neutralized by the slow addition of solid sodium bicarbonate. The crude mixture was extracted with diethyl ether (3.x.150 mL) and the combined organic layer was concentrated under reduced pressure to afford 2-(methylthio)pyrimidine-4-carbaldehyde (4) as a yellow solid (14.2 g, 41.5 g theoretical, 34percent). LC-MS m/z 155 (M+1). Reference: WO 2006/009734 A1, pg 67.
34%
Stage #1: at 60℃; for 3 h;
Stage #2: at 20℃;
4-(dimethoxymethyl)-2- (methylthio)pyrimidine (3) (53.7 g, 268 mmol) was added carefully to 1 .2 N aqueous HCl (300 mL, 268 mmol, 1 .0 equiv.) and stirred at 60°C for 3hours. The reaction mixture was then cooled to room temperature and neutralized by the slow addition of solid sodium bicarbonate. The crude mixture was extracted with diethyl ether (3 x 1 50 mL) and the combined organic layer was concentrated under reduced pressure to afford 2- (methylthio)pyrimidine-4-carbaldehyde (4) as a yellow solid ( 14.2 g, 41.5 g theoretical, 34percent). LC-MS m/z 1 55 (M+ 1 ). Reference: W2006009734A 1 , pg 67.
34% With hydrogenchloride In water at 60℃; for 3 h; 2-(methylthio)pyrimidine-4-carbaldehyde(6): 4-(dimethoxymethyl)-2-(methylthio)pyrimidine(5) (53.7 g, 268 mmol) was added carefully to 1.2 N aqueous HCl (300 mL,268 mmol, 1.0 equiv.) and stirred at 60°C for 3 hours. The reaction mixture was then cooled to room temperature and neutralized by the slow addition of solid sodiumbicarbonate. The crude mixture wasextracted with diethyl ether (3 x 150 mL) and the combined organic layer was concentrated under reduced pressure to afford 2-(methylthio)pyrimidine-4-carbaldehyde (6) as a yellow solid (14.2g, 41.5 g theoretical, 34percent). LC-MSm/z 155 (M+1).
96% With conc H2SO4 In glacial AcOH; dichloromethane c)
2-Methylthiopyrimidine-4-carboxaldehyde
2-Methylthiopyrimidine-4-carboxaldehyde dimethyl acetal (30.0 g, 150 mmol) was dissolved in 300 mL of glacial AcOH and 3 mL of conc H2SO4 and heated at 80° C.
After 10 h, the solution was cooled to 25° C. and the AcOH was removed in vacuo.
The residue was diluted in 200 mL of CH2Cl2 and washed with saturated NaHCO3 (3*50 mL), H2O (50 mL) and brine (50 mL).
The organics were dried (MgSO4) and concentrated to give the title compound as a brown oil; yield 22.1 g (96percent); or

Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 3, p. 1067 - 1088
[2] Patent: WO2016/7966, 2016, A2, . Location in patent: Paragraph 0024
[3] Journal of Medicinal Chemistry, 2018,
[4] Patent: US2011/152235, 2011, A1, . Location in patent: Page/Page column 67
[5] Patent: WO2011/103289, 2011, A2, . Location in patent: Page/Page column 73; 74
[6] Patent: US2012/270892, 2012, A1, . Location in patent: Page/Page column 57
[7] Tetrahedron Letters, 2015, vol. 56, # 23, p. 3186 - 3190
[8] Bioorganic and Medicinal Chemistry Letters, 1998, vol. 8, # 22, p. 3111 - 3116
[9] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 9, p. 1123 - 1126
[10] Patent: US2005/113392, 2005, A1, . Location in patent: Page/Page column 20
[11] Patent: US5658903, 1997, A,
[12] Patent: US5739143, 1998, A,
[13] Patent: US6218537, 2001, B1,
[14] Patent: US6218537, 2001, B1,
[15] Patent: US2003/225082, 2003, A1, . Location in patent: Page 9; 8
[16] Patent: WO2015/97123, 2015, A1, . Location in patent: Page/Page column 135
  • 3
  • [ 497-19-8 ]
  • [ 180869-36-7 ]
  • [ 1074-68-6 ]
YieldReaction ConditionsOperation in experiment
97% With hydrogenchloride In ethyl acetate b
2-Methylthiopyrimidine-4-carboxaldehyde
The product of example 1(a) (9.96 g, 50 mmol), and 3 N HCl (42 mL, 126 mmol) were combined and stirred at 48° C. for 16 h, cooled to 23° C., combined with EtOAc (200 mL) and made basic by the addition of solid Na2 CO3 (12.6 g, 150 mmol).
The aqueous phase was extracted with EtOAc (4*150 mL, dried (Na2 SO4), concentrated and the residue was filtered through a pad of silica (ca 150 mL) with CH2 Cl2 to afford 7.49 g (97percent) of the title compound 1 H NMR (CDCl3): δ9.96 (s,1), 8.77 (d, 1), 7.44 (d, 1), 2.62 (s,3).
97% With hydrogenchloride In ethyl acetate b
2-Methylthiopyrimidine-4-carboxaldehyde
The product of example 1(a) (9.96 g, 50 mmol), and 3 N HCl (42 mL, 126 mmol) were combined and stirred at 48° C. for 16 h, cooled to 23° C., combined with EtOAc (200 mL) and made basic by the addition of solid Na2 CO3 (12.6 g, 150 mmol).
The aqueous phase was extracted with EtOAc (4*150 mL, dried (Na2 DO4), concentrated and the residue was filtered through a pad of silica (ca 150 mL) with CH2 Cl2 to afford 7.49 g (97percent) of the title compound 1 H NMR (CDCl3): δ 9.96 (s,1), 8.77 (d, 1), 7.44 (d, 1), 2.62 (s,3).
97% With hydrogenchloride In ethyl acetate b
2-Methylthiopyrimidine-4-carboxaldehyde
The product of example 1(a) (9.96 g, 50 mmol), and 3N HCl (42 mL, 126 mmol) were combined and stirred at 48° C. for 16 h, cooled to 23° C., combined with EtOAc (200 mL) and made basic by the addition of solid Na2 CO3 (12.6 g, 150 mmol).
The aqueous phase was extracted with EtOAc (4*150 mL, dried (Na2 SO4), concentrated and the residue was filtered through a pad of silica (ca 150 mL) with CH2 Cl2 to afford 7.49 g (97percent) of the title compound 1 H NMR (CDCl3): δ9.96 (s,1), 8.77 (d, 1), 7.44 (d, 1), 2.62 (s,3).
Reference: [1] Patent: US5977103, 1999, A,
[2] Patent: US6046208, 2000, A,
[3] Patent: US5756499, 1998, A,
  • 4
  • [ 6342-56-9 ]
  • [ 180869-36-7 ]
  • [ 74-88-4 ]
  • [ 1074-68-6 ]
Reference: [1] Patent: US2004/38971, 2004, A1,
[2] Patent: US2004/87639, 2004, A1,
[3] Patent: US2005/148610, 2005, A1,
  • 5
  • [ 180869-36-7 ]
  • [ 1074-68-6 ]
Reference: [1] Patent: US5593991, 1997, A,
[2] Patent: US5593992, 1997, A,
[3] Patent: US5670527, 1997, A,
  • 6
  • [ 68-12-2 ]
  • [ 1122-74-3 ]
  • [ 1074-68-6 ]
Reference: [1] Tetrahedron, 2000, vol. 56, # 2, p. 265 - 273
  • 7
  • [ 180869-36-7 ]
  • [ 1074-68-6 ]
Reference: [1] Patent: US5658903, 1997, A,
  • 8
  • [ 1074-68-6 ]
  • [ 102921-92-6 ]
Reference: [1] Patent: US2009/82379, 2009, A1, . Location in patent: Page/Page column 19
[2] Patent: US2009/82329, 2009, A1, . Location in patent: Page/Page column 28
[3] Patent: WO2015/97123, 2015, A1, . Location in patent: Page/Page column 133; 135
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1074-68-6 ]

Aldehydes

Chemical Structure| 90905-31-0

[ 90905-31-0 ]

2-(Methylthio)pyrimidine-5-carbaldehyde

Similarity: 0.74

Chemical Structure| 2435-50-9

[ 2435-50-9 ]

Pyrimidine-4-carbaldehyde

Similarity: 0.69

Chemical Structure| 770-31-0

[ 770-31-0 ]

4-Amino-2-(methylthio)pyrimidine-5-carbaldehyde

Similarity: 0.63

Chemical Structure| 1004-17-7

[ 1004-17-7 ]

2-Methylpyrimidine-4-carbaldehyde

Similarity: 0.61

Chemical Structure| 185040-32-8

[ 185040-32-8 ]

4-(Methylamino)-2-(methylthio)pyrimidine-5-carbaldehyde

Similarity: 0.59

Sulfides

Chemical Structure| 496863-48-0

[ 496863-48-0 ]

1-(2-(Methylthio)pyrimidin-4-yl)ethanone

Similarity: 0.90

Chemical Structure| 1126-44-9

[ 1126-44-9 ]

2-Methylsulfanylpyrimidine-4-carboxylic acid

Similarity: 0.84

Chemical Structure| 1312095-44-5

[ 1312095-44-5 ]

(2-(Methylthio)pyrimidin-4-yl)methanamine

Similarity: 0.81

Chemical Structure| 102921-92-6

[ 102921-92-6 ]

(2-(Methylthio)pyrimidin-4-yl)methanol

Similarity: 0.80

Chemical Structure| 1124-75-0

[ 1124-75-0 ]

2-(Methylthio)-4-pyrimidinecarbonitrile

Similarity: 0.80

Related Parent Nucleus of
[ 1074-68-6 ]

Pyrimidines

Chemical Structure| 496863-48-0

[ 496863-48-0 ]

1-(2-(Methylthio)pyrimidin-4-yl)ethanone

Similarity: 0.90

Chemical Structure| 1126-44-9

[ 1126-44-9 ]

2-Methylsulfanylpyrimidine-4-carboxylic acid

Similarity: 0.84

Chemical Structure| 1312095-44-5

[ 1312095-44-5 ]

(2-(Methylthio)pyrimidin-4-yl)methanamine

Similarity: 0.81

Chemical Structure| 102921-92-6

[ 102921-92-6 ]

(2-(Methylthio)pyrimidin-4-yl)methanol

Similarity: 0.80

Chemical Structure| 1124-75-0

[ 1124-75-0 ]

2-(Methylthio)-4-pyrimidinecarbonitrile

Similarity: 0.80